欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
203	Polymyxin B sulfate	North China Pharmaceutical Huasheng Co., Ltd. Shijiazhuang CN	100021261;100029965	CEP 2024-323 - Rev 00	2025/07/11	Valid	11/07/2030	Chemical	2025/07/11	New application\|CEP granted\|11/07/2025
1182	Calcium ascorbate dihydrate	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2002-253 - Rev 02	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|CEP granted\|19/03/2024; Monograph revision\|Accepted - CEP remains valid\|03/08/2023
1069	Betacarotene	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2010-383 - Rev 02	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025
1559	Risperidone	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2003-110 - Rev 06	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Minor revision\|CEP granted\|02/05/2023; Notification\|CEP granted\|23/02/2022; Minor revision\|CEP granted\|03/09/2020
1046	Tamoxifen citrate	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 1999-180 - Rev 07	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Notification\|CEP granted\|21/12/2021; Notification\|CEP granted\|07/12/2020
761	Dexpanthenol	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 1997-113 - Rev 04	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Monograph revision\|CEP granted\|22/04/2021
543	Carbamazepine	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2000-164 - Rev 06	2025/07/11	Valid		Chemical	2025/07/11	Notification\|CEP granted\|11/07/2025; Notification\|CEP granted\|21/12/2021
1745	Carvedilol	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2003-048 - Rev 07	2025/07/11	Valid		Chemical	2025/12/11	Notification\|Accepted - CEP remains valid\|11/12/2025; Notification\|CEP granted\|11/07/2025; Notification\|CEP granted\|23/02/2022; Notification\|CEP granted\|19/10/2020
574	Cholecalciferol concentrate (powder form), 100 000 IU/g, with all-rac-α-tocopherol	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	100053293;100094111	CEP 2015-199 - Rev 01	2025/07/11	Valid		Chemical and TSE	2025/11/27	Notification\|Accepted - CEP remains valid\|27/11/2025; Notification\|CEP granted\|11/07/2025; Renewal\|CEP granted\|03/09/2021; Minor revision\|CEP granted\|13/08/2020
1559	Risperidone	AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad IN	100046306;100076393	CEP 2024-147 - Rev 00	2025/07/11	Valid	11/07/2030	Chemical	2025/07/11	New application\|CEP granted\|11/07/2025
253	Ascorbic acid	HEILONGJIANG NHU BIOTECHNOLOGY CO. LTD Suihua City CN	100047549;100078532	CEP 2023-349 - Rev 01	2025/07/10	Valid	19/11/2029	Chemical	2025/07/10	Minor revision\|CEP granted\|10/07/2025; New application\|CEP granted\|19/11/2024
2780	Temozolomide	FORMOSA LABORATORIES, INC. Taoyuan TW	100011879;100018688	CEP 2017-245 - Rev 02	2025/07/09	Valid		Chemical	2025/07/09	Notification\|CEP granted\|09/07/2025; Renewal\|CEP granted\|26/04/2024; Notification\|Accepted - CEP remains valid\|07/07/2022
1004	Diltiazem hydrochloride	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 1997-077 - Rev 16	2025/07/09	Valid		Chemical	2025/09/16	Notification\|Accepted - CEP remains valid\|16/09/2025; Minor revision\|CEP granted\|09/07/2025; Notification\|CEP granted\|12/03/2025; Notification\|Accepted - CEP remains valid\|10/10/2024; Minor revision\|CEP granted\|13/12/2021; Minor revision\|CEP granted\|25/09/2020
1472	Sodium hyaluronate, Intrinsic viscosity 2.93 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use	KEWPIE CORP. Tokyo JP	100039277;100093553	CEP 2019-064 - Rev 01	2025/07/09	Valid		Chemical and TSE	2025/07/09	Renewal\|CEP granted\|09/07/2025; Minor revision\|Accepted - CEP remains valid\|01/12/2020
2330	Leflunomide	FORMOSA LABORATORIES, INC. Taoyuan TW	100011879;100018688	CEP 2009-035 - Rev 03	2025/07/09	Valid		Chemical	2025/07/09	Notification\|CEP granted\|09/07/2025; Minor revision\|CEP granted\|12/05/2025
734	Prednisolone acetate, Micronised, sterile, alternative process	FARMABIOS S.p.A Gropello Cairoli IT	100011643;100021232	CEP 2024-549 - Rev 00	2025/07/09	Valid	09/07/2030	Chemical	2025/07/09	New application\|CEP granted\|09/07/2025
3132	Mirabegron, α-Form	MSN LABORATORIES PRIVATE LIMITED Rudraram Village IN	100011732;100018657	CEP 2024-031 - Rev 00	2025/07/09	Valid	09/07/2030	Chemical	2025/07/09	New application\|CEP granted\|09/07/2025
2591	Celecoxib	AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad IN	100046306;100076393	CEP 2019-112 - Rev 01	2025/07/09	Valid		Chemical	2026/01/07	Renewal\|Accepted - CEP remains valid\|07/01/2026; Minor revision\|CEP granted\|09/07/2025
2640	Atomoxetine hydrochloride, Process 2	COHANCE LIFESCIENCES LIMITED Mumbai IN	100011755;100090273	CEP 2019-212 - Rev 03	2025/07/09	Valid		Chemical	2025/07/09	Renewal\|CEP granted\|09/07/2025; Notification\|CEP granted\|10/07/2024; Notification\|CEP granted\|12/02/2021
929	Loperamide hydrochloride	TAPI NL B.V. Amsterdam NL	100003852;100094134	CEP 2008-313 - Rev 04	2025/07/08	Valid		Chemical	2025/07/08	Notification\|CEP granted\|08/07/2025; Minor revision\|Accepted - CEP remains valid\|19/06/2024; Minor revision\|Accepted - CEP remains valid\|08/08/2022; Notification\|CEP granted\|04/01/2022; Notification\|Accepted - CEP remains valid\|02/02/2021

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-